Fund profile

Enso Ventures

United Kingdom

Leading

About

Enso Ventures is a private investment firm founded in 2010, with offices in London and New York. The firm focuses on selective equity investments in high-technology and biotechnology companies, particularly in Europe and the United States. Enso Ventures leverages its industry expertise and capital to accelerate the commercial development of startup companies in fields like materials technology and life sciences. Enso Ventures typically participates in Series A rounds and later, with an average round size of around $6 million. The firm has built a portfolio of 15 companies, with 7 successful exits to date. Notable investments include companies like Cavion, which focuses on innovative pharmaceutical solutions, NeuroVia, specializing in drug discovery, and Seres Therapeutics, a leader in biotechnology. Enso Ventures aims to back startups that are poised to drive significant advancements in their industries, with a focus on developing disruptive technologies in both the biotech and materials tech sectors.

Details

Round

SeedSeries ASeries BSeries C+

Geo focus

Highlights

$5.2M

Historical average check

$26.1M

Historical max check

October 2017

Last investment date

15

Investments

Biotech

Healthtech & Wellness

Pharma

Natural Resources

Software & Apps

Security & Privacy

Hardware. Robotics & IoT

Real Estate & Proptech

Media, Events & Entertainment

Funds that also invest in Software & Apps